(Press-News.org) AUGUSTA, Ga. – A drug prescribed for Parkinson's disease may also treat restless leg syndrome without the adverse side effects of current therapies, Medical College of Georgia researchers say.
Rasagaline works by prolonging the effect of dopamine, a chemical that transmits signals between nerve cells in the brain. The cause of RLS is unknown, but research suggests a dopamine imbalance. Parkinson's is caused by a dopamine insufficiency.
"The hope is that Rasagaline, because it prolongs the effect of existing dopamine, instead of producing more, will not come with adverse side effects," said Dr. Shyamal Mehta, an MCG neurologist and neuroscientist. "We are trying to evaluate its safety and efficacy in treating RLS at this point. When it has been used to treat Parkinson's, it's been well-tolerated with few side effects."
Current RLS therapies include a group drugs that work by activating existing dopamine receptors, prompting the brain to make more dopamine. The problem, Mehta said, is that those drugs usually come with adverse effects, because dopamine increases feelings of euphoria.
"People taking those drugs often report behavioral problems like addiction, because the pleasure they get from things like shopping is multiplied," he said. "They can cause impulse-control problems, like gambling or hypersexuality as well. They can also cause increased sleepiness and sudden sleep attacks, which can be quite disruptive and dangerous."
Some reports also suggest decreased efficacy after extended use, as well as symptoms beginning earlier in the day.
Restless leg syndrome, which affects 10 percent of the population, is characterized by prickling or tingling in the legs and an urge to move the legs. Symptoms are more noticeable at rest, such as during bedtime or a long car ride. RLS can also cause depression and daytime sleepiness, Dr. Mehta said, and is linked to conditions including iron deficiency, renal failure, pregnancy and Parkinson's.
INFORMATION:
MCG is one of seven centers participating in the 14-week trial, which will enroll 52 participants nationally. Participants must have an RLS diagnosis and be off any related medications for at least 30 days before the study.
For more information, contact the MCG Movement Disorders Program at 706-721-2798.
Parkinson's drug could treat restless leg syndrome
2010-12-07
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Mayo Clinic finds long-term prognosis is excellent for most children with seizures
2010-12-07
ROCHESTER, Minn. -- Mayo Clinic researchers studied more than 200 children with epilepsy and found that even if the cause of focal-onset seizures cannot be identified and they do not fit into a known epilepsy syndrome, long-term prognosis is still excellent. This study was presented at the American Epilepsy Society's (http://www.aesnet.org/) annual meeting in San Antonio on Dec. 4.
Epilepsy (http://www.mayoclinic.org/epilepsy/) is a disorder characterized by the occurrence of two or more seizures. It affects almost 3 million Americans, and approximately 45,000 children ...
Scientists announce discovery of first horned dinosaur from South Korea
2010-12-07
Cleveland - Scientists from South Korea, the United States and Japan analyzed fossil evidence found in South Korea and published research describing a new horned dinosaur. The newly identified genus, Koreaceratops hwaseongensis, lived about 103 million years ago during the late Early Cretaceous period. The specimen is the first ceratopsian dinosaur from the Korean peninsula. The partial skeleton includes a significant portion of the animal's backbone, hip bone, partial hind limbs and a nearly complete tail. Results from the analysis of the specimen were published in ...
Penn study on skin formation suggests strategies to fight skin cancer
2010-12-07
PHILADELPHIA - In a study published in the journal Developmental Cell, Sarah Millar PhD, professor of Dermatology and Cell & Developmental Biology at the University of Pennsylvania School of Medicine, and colleagues demonstrate that a pair of enzymes called HDACs are critical to the proper formation of mammalian skin.
The findings, Millar says, not only provide information about the molecular processes underlying skin development, they also suggest a potential anticancer strategy. "Inhibition of these HDAC enzymes might be able to shut down the growth of tumors that ...
Bacteria seek to topple the egg as top flu vaccine tool
2010-12-07
Only the fragile chicken egg stands between Americans and a flu pandemic that would claim tens of thousands more lives than are usually lost to the flu each year.
Vaccine production hinges on the availability of hundreds of millions of eggs – and even with the vaccine, flu still claims somewhere around 36,000 lives in the United States during a typical year. Now scientists have taken an important step toward ending the dominance of the oval. In a paper published in the Dec. 6 issue of the journal Vaccine, scientists showed that an experimental flu vaccine grown entirely ...
NIH scientists identify mechanism responsible for spreading biofilm infections
2010-12-07
What: Scientists from the National Institutes of Health have discovered how catheter-related bacterial infection develops and disseminates to become a potentially life-threatening condition. The study, which included research on Staphylococcus epidermidis in mice implanted with catheters, could have important implications for understanding many types of bacterial biofilm infections, including those caused by methicillin-resistant S. aureus (MRSA).
Biofilms are clusters of microbes that almost always are found with healthcare-associated infections (HAIs) involving medical ...
Iron deficiency in soil threatens soybean production
2010-12-07
Madison, WI December 6 2010 -- An expansion of soybean production into areas where soybean has seldom, if ever, been grown can be problematic for some farmers. Soils having high pH values and large amounts of calcium and/or magnesium carbonate are notoriously iron deficient. Iron deficient soils in the North Central United States are estimated to reduce soy bean production by 12.5 million bushels every year.
John Wiersma, a researcher at the University of Minnesota Northwest Research and Outreach Center at Crookston, concluded a study examining the effect of nitrogen based ...
UNC expert: Combining exenatide with insulin may be 'best result ever' for diabetes patients
2010-12-07
CHAPEL HILL, N.C. – A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.
"This study may be the best result ever for patients whose diabetes is inadequately controlled on a combination of pills and insulin," said John Buse, MD, PhD, lead author of the study and chief of the Division of Endocrinology and Metabolism in the University of North Carolina at Chapel Hill School of Medicine.
"Until now, it was inconceivable that you ...
Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
2010-12-07
(ORLANDO, Fla.) – A personalized vaccine is a powerful therapy to prevent recurrence among certain follicular lymphoma patients, according to the latest results of ongoing research led by the University of Pennsylvania School of Medicine. The new findings show that when these patients – whose tumors are marked by a specific protein that may be present in up to half of people with this type of cancer -- receive a vaccine made from their own tumor cells, disease-free survival is improved by nearly two years, compared with patients who receive a placebo. Based on the new analysis, ...
Learning the language of bacteria
2010-12-07
MADISON — Bacteria are among the simplest organisms in nature, but many of them can still talk to each other, using a chemical "language" that is critical to the process of infection. Sending and receiving chemical signals allows bacteria to mind their own business when they are scarce and vulnerable, and then mount an attack after they become numerous enough to overwhelm the host's immune system.
This system, called "quorum sensing," is an interesting example of sophistication among microbes, says Helen Blackwell, an associate professor of chemistry at the University ...
Mammogram sensitivity depends on menstrual cycle
2010-12-07
SEATTLE—Try to schedule your screening mammogram during the first week of your menstrual cycle. It might make breast cancer screening more accurate for pre-menopausal women who choose to have regular mammograms. This recommendation comes from an article published online December 3 in Radiology by Diana Miglioretti, PhD, a senior investigator at Group Health Research Institute.
Dr. Miglioretti and her co-authors are working on an issue at the heart of recent controversies about breast cancer screening mammograms. In November 2009, new recommendations—including that women ...